Treatment of metabolic disorders in equine animals

Treatment of metabolic disorders in equine animals

The present invention relates to one or more SGLT2 inhibitors or pharmaceutically acceptable forms thereof for use in the treatment and/or prevention of a metabolic disorder of an equine animal. In particular, the present invention relates to one or more SGLT2 inhibitors or a pharmaceutically accept...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: REICHE, Dania Birte, SOMERVILLE, Bruce, VOTH, Rebecca K, JOHNSTON, Laura, MOHREN, Nicole
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator REICHE, Dania Birte
SOMERVILLE, Bruce
VOTH, Rebecca K
JOHNSTON, Laura
MOHREN, Nicole
description The present invention relates to one or more SGLT2 inhibitors or pharmaceutically acceptable forms thereof for use in the treatment and/or prevention of a metabolic disorder of an equine animal. In particular, the present invention relates to one or more SGLT2 inhibitors or a pharmaceutically acceptable form thereof for 5 use in the treatment and/or prevention of laminitis, vascular dysfunction, hypertension, hepatic lipidosis, atherosclerosis, hyperadrenocorticism, Pituitary Pars Intermedia Dysfunction and/or Equine Metabolic Syndrome in an equine animal.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2021240192A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2021240192A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2021240192A13</originalsourceid><addsrcrecordid>eNrjZDAKKUpNLMlNzStRyE9TyE0tSUzKz8lMVkjJLM4vSkktKlbIzFNILSzNzEtVSMzLzE3MKeZhYE0DUqm8UJqbQdnNNcTZQze1ID8-tbggMTk1L7Uk3jHUyMDI0MjEwNDSyNHQmDhVAIAaLOI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Treatment of metabolic disorders in equine animals</title><source>esp@cenet</source><creator>REICHE, Dania Birte ; SOMERVILLE, Bruce ; VOTH, Rebecca K ; JOHNSTON, Laura ; MOHREN, Nicole</creator><creatorcontrib>REICHE, Dania Birte ; SOMERVILLE, Bruce ; VOTH, Rebecca K ; JOHNSTON, Laura ; MOHREN, Nicole</creatorcontrib><description>The present invention relates to one or more SGLT2 inhibitors or pharmaceutically acceptable forms thereof for use in the treatment and/or prevention of a metabolic disorder of an equine animal. In particular, the present invention relates to one or more SGLT2 inhibitors or a pharmaceutically acceptable form thereof for 5 use in the treatment and/or prevention of laminitis, vascular dysfunction, hypertension, hepatic lipidosis, atherosclerosis, hyperadrenocorticism, Pituitary Pars Intermedia Dysfunction and/or Equine Metabolic Syndrome in an equine animal.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20211028&amp;DB=EPODOC&amp;CC=AU&amp;NR=2021240192A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20211028&amp;DB=EPODOC&amp;CC=AU&amp;NR=2021240192A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>REICHE, Dania Birte</creatorcontrib><creatorcontrib>SOMERVILLE, Bruce</creatorcontrib><creatorcontrib>VOTH, Rebecca K</creatorcontrib><creatorcontrib>JOHNSTON, Laura</creatorcontrib><creatorcontrib>MOHREN, Nicole</creatorcontrib><title>Treatment of metabolic disorders in equine animals</title><description>The present invention relates to one or more SGLT2 inhibitors or pharmaceutically acceptable forms thereof for use in the treatment and/or prevention of a metabolic disorder of an equine animal. In particular, the present invention relates to one or more SGLT2 inhibitors or a pharmaceutically acceptable form thereof for 5 use in the treatment and/or prevention of laminitis, vascular dysfunction, hypertension, hepatic lipidosis, atherosclerosis, hyperadrenocorticism, Pituitary Pars Intermedia Dysfunction and/or Equine Metabolic Syndrome in an equine animal.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAKKUpNLMlNzStRyE9TyE0tSUzKz8lMVkjJLM4vSkktKlbIzFNILSzNzEtVSMzLzE3MKeZhYE0DUqm8UJqbQdnNNcTZQze1ID8-tbggMTk1L7Uk3jHUyMDI0MjEwNDSyNHQmDhVAIAaLOI</recordid><startdate>20211028</startdate><enddate>20211028</enddate><creator>REICHE, Dania Birte</creator><creator>SOMERVILLE, Bruce</creator><creator>VOTH, Rebecca K</creator><creator>JOHNSTON, Laura</creator><creator>MOHREN, Nicole</creator><scope>EVB</scope></search><sort><creationdate>20211028</creationdate><title>Treatment of metabolic disorders in equine animals</title><author>REICHE, Dania Birte ; SOMERVILLE, Bruce ; VOTH, Rebecca K ; JOHNSTON, Laura ; MOHREN, Nicole</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2021240192A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>REICHE, Dania Birte</creatorcontrib><creatorcontrib>SOMERVILLE, Bruce</creatorcontrib><creatorcontrib>VOTH, Rebecca K</creatorcontrib><creatorcontrib>JOHNSTON, Laura</creatorcontrib><creatorcontrib>MOHREN, Nicole</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>REICHE, Dania Birte</au><au>SOMERVILLE, Bruce</au><au>VOTH, Rebecca K</au><au>JOHNSTON, Laura</au><au>MOHREN, Nicole</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Treatment of metabolic disorders in equine animals</title><date>2021-10-28</date><risdate>2021</risdate><abstract>The present invention relates to one or more SGLT2 inhibitors or pharmaceutically acceptable forms thereof for use in the treatment and/or prevention of a metabolic disorder of an equine animal. In particular, the present invention relates to one or more SGLT2 inhibitors or a pharmaceutically acceptable form thereof for 5 use in the treatment and/or prevention of laminitis, vascular dysfunction, hypertension, hepatic lipidosis, atherosclerosis, hyperadrenocorticism, Pituitary Pars Intermedia Dysfunction and/or Equine Metabolic Syndrome in an equine animal.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2021240192A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Treatment of metabolic disorders in equine animals
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T12%3A15%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=REICHE,%20Dania%20Birte&rft.date=2021-10-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2021240192A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true